References
- Sams WM Jr. Small vessel vasculitis. In: Sams WM Jr, Lynch PJ, eds. Principles and practice of dermatology. New York: Churchill Livingstone, 1990: 523–6
- Callen JP. Cutaneous leukocytoclastic vasculitis: clinical and therapeutic considerations. Yale University/Glaxo Dermatology Lectureship Series in Dermatology. Interaction Projects: Newtown, Conn, 1992: 1–19
- Callen JP. Vasculitis. In: Callen JP, Jorizzo JL, Greer KE, et al, eds. Dermatological signs of internal disease. 2d ed. Philadelphia: WB Saunders, 1995: 31–4
- Kane KS, Moschella SL, Magro CM. Serious skin signs: purpura. Fitz J Clin Dermatol 1995; 3(1): 50–6
- Calabrese LH, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990; 33(8): 1108–13
- Gibson LE. Cutaneous vasculitis: approach to diagnosis and systemic associations. Mayo Clin Proc 1990; 65(2): 221–9
- Soter NA. Cutaneous necrotizing venulitis. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Dermatology in general medicine. 4th ed. New York: McGraw-Hill, Health Professions Division, 1993: 1501–10
- Cupps TR, Springer RM, Fauci AS. Chronic, recurrent small-vessel cutaneous vasculitis: clinical experience in 13 patients. JAMA 1982; 247(14): 1994–8
- Callen JP. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 1985; 13(2 Pt 1): 193–200
- Sais G, Vidaller A, Jucglà A, et al. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis: results of a prospective, randomized controlled trial. Arch Dermatol 1995; 131(12): 1399–402
- Houck HE, Kauffman CL, Casey DL. Minocycline treatment for leukocytoclastic vasculitis associated with rheumatoid arthritis. Arch Dermatol 1997; 133(1): 15–6